Sintx Technologies, Inc. SEC filings SINT

Sintx Technologies, Inc. has 660 filings in SEC EDGAR's recent list, going back to Nov 3, 2003. Its latest annual report, Form 10-K, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Mar 20, 2026 Dec 31, 2025
10-K Annual report Mar 19, 2025 Dec 31, 2024
10-K Annual report Mar 27, 2024 Dec 31, 2023
10-K Annual report Mar 29, 2023 Dec 31, 2022
10-K Annual report Mar 25, 2022 Dec 31, 2021
10-K Annual report Mar 22, 2021 Dec 31, 2020
10-K Annual report Mar 26, 2020 Dec 31, 2019
10-K Annual report Mar 11, 2019 Dec 31, 2018
10-K Annual report Mar 29, 2018 Dec 31, 2017
10-K/A Amended annual report Dec 27, 2017 Dec 31, 2016
10-K/A Amended annual report Dec 12, 2017 Dec 31, 2016
10-K Annual report Sep 20, 2017 Dec 31, 2016
10-K Annual report Mar 23, 2016 Dec 31, 2015
10-K/A Amended annual report Dec 17, 2015 Dec 31, 2014
10-K Annual report Mar 24, 2015 Dec 31, 2014
10-K Annual report Mar 31, 2014 Dec 31, 2013

Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
SINT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Salt Lake City, UT
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1269026
Former names
AMEDICA CORP (until Oct 5, 2018); AMEDICA Corp (until Oct 5, 2018)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.